Aziyo Biologics, Inc Earning Date (AZYO)

USA |NASDAQ |USD

AZYO Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Aug 8, 2022 Jun 2022 - - $-0.23
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Aug 8, 2022 Jun 2022 - - $12.16M

Aziyo Biologics, Inc's next earnings date is Monday, Aug 8, 2022 for the fiscal quarter ending Jun 2022.

AZYO Earnings Date & History Chart

AZYO Earnings & Revenue Forecast

AZYO Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 4 $-1.78 $-2.11 $-1.34

AZYO Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 0 / 0 $-1.78 $-1.78 $-1.55

AZYO Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 4 $59.58M $55.34M $63.90M

AZYO Earnings Date & Revenue History

AZYO Earnings History

|
Show More
Show More

AZYO Revenue History

|
Show More
Show More

Aziyo Biologics, Inc Next Earnings Date & Report

AZYO Next Earnings Date & Report Preview: Jun 2022 (FQ)

AZYO's next earnings date is Monday, Aug 8, 2022 for the fiscal quarter ending Jun 30, 2022.

Aziyo Biologics, Inc Previous Earnings Dates & Reports

AZYO Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Aziyo Biologics, Inc's previous earnings date was May 9, 2022 for its fiscal quarter ended Mar 31, 2022.

AZYO Previous Earnings Date & Report Recap: Dec 2021 (FY)

Aziyo Biologics, Inc's previous annual earnings date was Mar 3, 2022 for its fiscal year ended Dec 31, 2021.

AZYO's earnings per share (EPS) was $-2.36, missing the consensus analysts forecast of $-2.00 by 18.00% , and higher than the previous year's EPS (Dec 2020) by -85.57%.

Revenues were $47.39M, worse than the forecast of $48.72M by -2.73%, and up by 11.03% from previous year's revenue.

The company reported a net income of $-24.83M.

Aziyo Biologics, Inc reported a free cash flow of $-15.81M for its fiscal year, compared to $-14.27M a year ago.

The company ended the fiscal year with $23.23M in total debt, a decrease of -24.17% compared to the previous year.